The future of tissue-agnostic drugs larotrectinib was

New Post Public Reply Private Reply Replies (0) Message Board
smlf
534

The future of tissue-agnostic drugs

Quote:
larotrectinib was approved on the basis of data from 3 trials, involving 55 adults and children with 17 kinds of advanced cancer. It found that tumours shrank by 30% or more in 34 people and completely disappeared in 7. The overall response rate was 75%. For entrectinib, approval was based on 3 trials that cumulatively enrolled 54 adults and found an overall response rate of 57%. But “the response rate doesn’t mean very much in terms of survival,” says Tannock.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Southwest Airlines Expands Network to St. Thomas by 2026

Updated Category News Views 365

Southwest Airlines to Launch New Service to St. Thomas Southwest Airlines Co. (NYSE: LUV) is delighted to announce its plan to expand its destination offerings by introducing flights to St. Thomas, a beautiful island in the U.S. Virgin Islands. This marks the airline's first major network addition since 2021, allowing travelers more options for tropical destinations....

Continue Reading
HUTCHMED Unveils Promising Data at ESMO Congress 2025

Updated Category News Views 258

HUTCHMED's Notable Presence at ESMO Congress 2025 HUTCHMED (China) Limited (NASDAQ: HCM; HKEX: 13) has exciting news as it prepares to present groundbreaking results from various studies at the European Society for Medical Oncology (ESMO) Congress 2025. This esteemed event, scheduled from October 17 to 21, will take place in a prominent European city known for its rich...

Continue Reading
Market Shifts: Analysts Downgrade General Dynamics and More

Updated Category News Views 85

Analysts Adjust Ratings: What You Need to Know Recent changes in analyst ratings have sparked interest among investors focused on major companies. These shifts can often indicate underlying trends that affect stock performance. Here, we examine crucial downgrades affecting some significant players in the market, particularly General Dynamics Corporation (NYSE: GD)....

Continue Reading
FDUSD Joins Solana Blockchain to Enhance Stablecoin Access

Updated Category News Views 80

First Digital Expands FDUSD to the Solana Blockchain First Digital Group, a leading name in digital asset custody and trust services, has made a significant move by deploying First Digital USD (FDUSD) onto the Solana blockchain. This expansion enhances the existing availability of FDUSD across other prominent networks such as Ethereum and BNB Chain. Strengthening Access...

Continue Reading
Transforming Employer Branding: CLEO Intelligence™ Unveiled

Updated Category News Views 377

Revolutionizing Employer Branding with CLEO Intelligence™ Cliquify proudly announces a groundbreaking innovation: CLEO Intelligence™, an advanced AI-driven data technology that is set to change the way organizations perceive and enhance their employer branding. This remarkable tool harnesses the power of data by analyzing millions of data points to provide a...

Continue Reading